Adalimumab RSS : Gourt http://www.gourt.com/Health/Pharmacy/Drugs-and-Medications/A/Adalimumab.html en-us Copyright 2007, Gourt.com 2009-11-06T04:54+13:00 rtruog@gourt.com rtruog@gourt.com Adalimumab RSS : Gourt hourly 1 1901-01-01T00:00+00:00 Approximately 60% with refractory Crohn’s show long-term response to adalimumab http://bit.ly/UvIos http://twitter.com/mdconsult/statuses/5461825388 RT @MedicalNewsNet: 60% W/ Refractory Crohn’s Show Long-Term Response to Adalimumab, reported by Mary Ann Moon for MNN: http://bit.ly/4hqGFA http://twitter.com/knwachter/statuses/5431459381 RT @MedicalNewsNet: 60% W Refractory Crohn’s Show Long-Term Response to Adalimumab, reported by Mary Ann Moon for MNN: http://bit.ly/4hqGFA http://twitter.com/MiriamETucker/statuses/5431192872 algumas drogas parecem ter sido batizadas por george lucas: anakinra, abatacept, rituximab, etanercept, infliximab, adalimumab, abciximab... http://twitter.com/tat_can/statuses/5407060579 Adalimumab Initially Effective in Infliximab-Resistant Ulcerative Colitis, But Effects Are Not Durable: Medscap.. http://bit.ly/2IqWT3 http://twitter.com/WATC/statuses/5366271797 MedScape: Adalimumab Initially Effective in Infliximab-Resistant Ulcerative Colitis, But Effects Are N.. http://bit.ly/2IqWT3 http://twitter.com/Balimore/statuses/5365471744 #infliximab and #adalimumab are associated with a 3 to 4-fold higher rate of #tuberculosis compared to #etanercept http://twitter.com/shilpanangali/statuses/5363034738 RT @NewInIBD: RE adalimumab study: serum levels & antibodies not commercially avail. It's time docs could monitor levels! http://ow.ly/xkkm http://twitter.com/MGlags/statuses/5285066931 RE adalimumab study: serum levels and antibodies are not commercially available. It's time docs could monitor levels! http://ow.ly/xkkm http://twitter.com/newinibd/statuses/5284087429 RT @AmerGastroAssn: Findings of a study into long-term benefit of adalimumab in #Crohn's patients who failed on iFX: http://ow.ly/xkkm http://twitter.com/newinibd/statuses/5284072297 RT @AmerGastroAssn: Findings of a study into long-term benefit of adalimumab in #Crohn's patients who failed on iFX: http://ow.ly/xkkm http://twitter.com/ericbenchimol/statuses/5284068026 RT @AmerGastroAssn Long-term benefit of adalimumab in #Crohn's patients who failed on infliximab. Gastro: http://ow.ly/xkkm http://twitter.com/CECSarahG/statuses/5265638827 Findings of a study into long-term benefit of adalimumab in #Crohn's patients who failed on infliximab. Gastro: http://ow.ly/xkkm http://twitter.com/AmerGastroAssn/statuses/5265399997 Eisai News: Abbott Submits Marketing Authorization Application of humiraâ® (adalimumab),.. http://bit.ly/2KHLtc #pharminews http://twitter.com/PW_EISA01/statuses/5255556519 Abbott Submits Marketing Authorization Application of humiraâ® (adalimumab), a ... http://bit.ly/CwG7l #pharminews http://twitter.com/pharminews/statuses/5255469124